{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:05:13Z","timestamp":1793387113266,"version":"4.5.0"},"reference-count":214,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T00:00:00Z","timestamp":1705276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100022854","name":"European Cystic Fibrosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022854","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jcf.2024.01.005","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T09:18:44Z","timestamp":1705396724000},"page":"187-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0903-9828","authenticated-orcid":false,"given":"Pierre-R\u00e9gis","family":"Burgel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin W","family":"Southern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4207-4409","authenticated-orcid":false,"given":"Charlotte","family":"Addy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Battezzati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Bouchara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0253-9678","authenticated-orcid":false,"given":"Edwin","family":"Brokaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4332-4112","authenticated-orcid":false,"given":"Whitney","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3874-5580","authenticated-orcid":false,"given":"Isabelle","family":"Durieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Ekkelenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5102-5783","authenticated-orcid":false,"given":"Felicity","family":"Finlayson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Forton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1619-0059","authenticated-orcid":false,"given":"Johanna","family":"Gardecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavla","family":"Hodkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9321-8399","authenticated-orcid":false,"given":"Gina","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Lowdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3815-9810","authenticated-orcid":false,"given":"Su","family":"Madge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"McKone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2331-278X","authenticated-orcid":false,"given":"Anne","family":"Munck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Y","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4970-8889","authenticated-orcid":false,"given":"Lucy","family":"Perrem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Piper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Prayle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Ratjen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8105-614X","authenticated-orcid":false,"given":"Margaret","family":"Rosenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6265-6249","authenticated-orcid":false,"given":"Don B","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Taccetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8389-3809","authenticated-orcid":false,"given":"Claire","family":"Wainwright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie E","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6223-5185","authenticated-orcid":false,"given":"Michael","family":"Wilschanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8372-4607","authenticated-orcid":false,"given":"Amanda","family":"Bevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1916-0963","authenticated-orcid":false,"given":"Carlo","family":"Castellani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8994-5240","authenticated-orcid":false,"given":"Pavel","family":"Drevinek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Gartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gramegna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1661-8687","authenticated-orcid":false,"given":"Elise","family":"Lammertyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddie (Edwina) C","family":"Landau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4611-6768","authenticated-orcid":false,"given":"Barry J","family":"Plant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5494-5438","authenticated-orcid":false,"given":"Alan R","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2222-4238","authenticated-orcid":false,"given":"Silke","family":"van Koningsbruggen-Rietschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3361-4941","authenticated-orcid":false,"given":"Peter G.","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2024.01.005_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2023.09.008","article-title":"Standards for the care of people with cystic fibrosis (CF): a timely and accurate diagnosis","author":"Castellani","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0002","article-title":"Standards for the care of people with cystic fibrosis; establishing and maintaining health","author":"Southern","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0003","article-title":"Standards for the care of people with cystic fibrosis (CF). Editorial","author":"Southern","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0004","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","article-title":"ECFS best practice guidelines: the 2018 revision","volume":"17","author":"Castellani","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0005","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167957","article-title":"Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density but lung infections generally persist","author":"Nichols","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcf.2024.01.005_bib0006","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/thoraxjnl-2020-216085","article-title":"Time to get serious about the detection and monitoring of early lung disease in cystic fibrosis","volume":"76","author":"Bayfield","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2024.01.005_bib0007","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00247-022-05522-4","article-title":"Chest radiography and computed tomography imaging in cystic fibrosis: current challenges and new perspectives","volume":"53","author":"Ciet","year":"2023","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.jcf.2024.01.005_bib0008","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0173-2021","article-title":"State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the \"iMAging managEment of cySTic fibROsis\" (MAESTRO) consortium","volume":"31","author":"Ciet","year":"2022","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jcf.2024.01.005_bib0009","first-page":"jmri.27030","article-title":"Current state of the art MRI for the longitudinal assessment of cystic fibrosis","volume":"10.1002","author":"Woods","year":"2019","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jcf.2024.01.005_bib0010","article-title":"Dornase alfa for cystic fibrosis","volume":"3","author":"Yang","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2024.01.005_bib0011","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/ppul.25248","article-title":"Epidemiologic study of cystic fibrosis: 25 years of observational research","volume":"56","author":"Konstan","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.01.005_bib0012","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1183\/09031936.95.08101786","article-title":"DNase trials in cystic fibrosis","volume":"8","author":"Hodson","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2024.01.005_bib0013","article-title":"Timing of dornase alfa inhalation for cystic fibrosis","volume":"3","author":"Dentice","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2024.01.005_bib0014","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S2213-2600(19)30187-0","article-title":"Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"7","author":"Ratjen","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcf.2024.01.005_bib0015","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001506.pub3","article-title":"Nebulised hypertonic saline for cystic fibrosis","author":"Wark","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2024.01.005_bib0016","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S2213-2600(21)00546-4","article-title":"The effect of inhaled hypertonic saline on lung structure in children aged 3-6 years with cystic fibrosis (SHIP-CT): a multicentre, randomised, double-blind, controlled trial","volume":"10","author":"Tiddens","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcf.2024.01.005_bib0017","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1164\/rccm.201807-1203OC","article-title":"Preventive inhalation of hypertonic saline in infants with cystic fibrosis (PRESIS). A randomized, double-blind, controlled study","volume":"199","author":"Stahl","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.01.005_bib0018","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00960-2021","article-title":"Saline at lower tonicity in cystic fibrosis (SALTI-CF) trial comparing 0.9% versus 3% versus 6% nebulised saline","volume":"62","author":"Dwyer","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2024.01.005_bib0019","article-title":"Inhaled mannitol for cystic fibrosis","volume":"5","author":"Nevitt","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2024.01.005_bib0020","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S2213-2600(22)00434-9","article-title":"Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials","volume":"11","author":"Mayer-Hamblett","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcf.2024.01.005_bib0021","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1183\/09031936.02.00268002","article-title":"Sequential genotyping of Pseudomonas aeruginosa from upper and lower airways of cystic fibrosis patients","volume":"20","author":"Jung","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2024.01.005_bib0022","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/(SICI)1099-0496(199911)28:5<321::AID-PPUL3>3.0.CO;2-V","article-title":"Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis","volume":"28","author":"Rosenfeld","year":"1999","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.01.005_bib0023","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jcf.2013.05.013","article-title":"Induced sputum compared to bronchoalveolar lavage in young, non-expectorating cystic fibrosis children","volume":"13","author":"Blau","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0024","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ppul.23150","article-title":"Sputum induction improves detection of pathogens in children with cystic fibrosis","volume":"50","author":"Hoppe","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.01.005_bib0025","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jcf.2016.01.001","article-title":"Microbiological yield from induced sputum compared to oropharyngeal swab in young children with cystic fibrosis","volume":"15","author":"Zampoli","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0026","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S2213-2600(18)30171-1","article-title":"The CF-Sputum Induction Trial (CF-SpIT) to assess lower airway bacterial sampling in young children with cystic fibrosis: a prospective internally controlled interventional trial","volume":"6","author":"Ronchetti","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcf.2024.01.005_bib0027","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1128\/JCM.02035-13","article-title":"Sampling and decontamination method for culture of nontuberculous mycobacteria in respiratory samples of cystic fibrosis patients","volume":"51","author":"De Bel","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcf.2024.01.005_bib0028","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1128\/JCM.02423-16","article-title":"Evaluation of RGM medium for isolation of nontuberculous mycobacteria from respiratory samples from patients with cystic fibrosis in the United States","volume":"55","author":"Plongla","year":"2017","journal-title":"J Clin Microbiol"},{"issue":"Suppl 1","key":"10.1016\/j.jcf.2024.01.005_bib0029","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jcf.2014.03.009","article-title":"European cystic fibrosis society standards of care: framework for the cystic fibrosis centre","volume":"13","author":"Conway","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0030","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jcf.2017.12.007","article-title":"One time quantitative PCR detection of Pseudomonas aeruginosa to discriminate intermittent from chronic infection in cystic fibrosis","volume":"17","author":"Boutin","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0031","series-title":"CF trust guidelines: laboratory standards for processing microbiological samples from people with cystic fibrosis","year":"2022"},{"key":"10.1016\/j.jcf.2024.01.005_bib0032","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1542\/peds.3.4.406","article-title":"Therapy and prognosis of fibrocystic disease of the pancreas","volume":"3","author":"Andersen","year":"1949","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2024.01.005_bib0033","article-title":"Prophylactic anti-staphylococcal antibiotics for cystic fibrosis","volume":"9","author":"Rosenfeld","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2024.01.005_bib0034","article-title":"Treatment for chronic methicillin-sensitive staphylococcus aureus pulmonary infection in people with cystic fibrosis","volume":"7","author":"Ahmed","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2024.01.005_bib0035","article-title":"Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis","volume":"12","author":"Lo","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2024.01.005_bib0036","article-title":"Vaccines for preventing infection with pseudomonas aeruginosa in cystic fibrosis","author":"Johansen","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2024.01.005_bib0037","article-title":"Antibiotic strategies for eradicating pseudomonas aeruginosa in people with cystic fibrosis","volume":"6","author":"Langton Hewer","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2024.01.005_bib0038","article-title":"Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis","volume":"11","author":"Smith","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.jcf.2024.01.005_bib0039","article-title":"Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis","author":"Waters","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.jcf.2024.01.005_bib0040","article-title":"Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis","author":"Regan","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.jcf.2024.01.005_bib0041","article-title":"Antibiotic therapy for chronic infection with burkholderia cepacia complex in people with cystic fibrosis","author":"Frost","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2024.01.005_bib0042","article-title":"Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis","volume":"3","author":"Amin","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2024.01.005_bib0043","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/cpt.2309","article-title":"Clinical pharmacogenetics implementation consortium guideline for the use of aminoglycosides based on MT-RNR1 Genotype","volume":"111","author":"McDermott","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jcf.2024.01.005_bib0044","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jcf.2012.06.005","article-title":"A cohort study of the Copenhagen CF Centre eradication strategy against Staphylococcus aureus in patients with CF","volume":"12","author":"Dalboge","year":"2013","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0045","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/thoraxjnl-2016-208949","article-title":"Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial","volume":"72","author":"Muhlebach","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2024.01.005_bib0046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta25650","article-title":"Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT","volume":"25","author":"Langton Hewer","year":"2021","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jcf.2024.01.005_bib0047","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jcf.2018.04.002","article-title":"Eradication of early P. aeruginosa infection in children <7years of age with cystic fibrosis: the early study","volume":"18","author":"Ratjen","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0048","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1513\/AnnalsATS.201404-166OC","article-title":"Cystic fibrosis foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection","volume":"11","author":"Mogayzel","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2024.01.005_bib0049","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/cid\/civ377","article-title":"Impact of sustained eradication of new pseudomonas aeruginosa infection on long-term outcomes in cystic fibrosis","volume":"61","author":"Mayer-Hamblett","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcf.2024.01.005_bib0050","article-title":"Sermet-Gaudelus I. A critical review of definitions used to describe pseudomonas aeruginosa microbiological status in patients with cystic fibrosis for application in clinical trials","author":"Taccetti","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0051","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jcf.2022.08.007","article-title":"Impact of antibiotic eradication therapy of Pseudomonas aeruginosa on long term lung function in cystic fibrosis","volume":"22","author":"Casaredi","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0052","article-title":"Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation","volume":"4","author":"Lord","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2024.01.005_bib0053","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1569-1993(02)00141-8","article-title":"Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients","volume":"2","author":"Lee","year":"2003","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0054","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jcf.2016.01.005","article-title":"Safety and efficacy of prolonged levofloxacin inhalation solution (APT-1026) treatment for cystic fibrosis and chronic Pseudomonas aeruginosa airway infection","volume":"15","author":"Elborn","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0055","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jcf.2019.08.001","article-title":"Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis","volume":"19","author":"Bilton","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0056","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1183\/09031936.00090314","article-title":"Inhaled antibiotics: dry or wet?","volume":"44","author":"Tiddens","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2024.01.005_bib0057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-1460-0_1","article-title":"Culturing mycobacteria","volume":"2314","author":"Wallace","year":"2021","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jcf.2024.01.005_bib0058","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/ciaa1125","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"71","author":"Daley","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcf.2024.01.005_bib0059","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/MCP.0b013e328365ab33","article-title":"Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis","volume":"19","author":"Leung","year":"2013","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jcf.2024.01.005_bib0060","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1055\/s-0033-1333574","article-title":"Nontuberculous mycobacteria in patients with cystic fibrosis","volume":"34","author":"Leung","year":"2013","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.01.005_bib0061","series-title":"Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes","article-title":"CLSI standards: guidelines for health care excellence","author":"Woods","year":"2011"},{"issue":"Suppl 1","key":"10.1016\/j.jcf.2024.01.005_bib0062","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thoraxjnl-2015-207360","article-title":"US cystic fibrosis foundation and European cystic fibrosis society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis","volume":"71","author":"Floto","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2024.01.005_bib0063","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1183\/09031936.99.14234799","article-title":"Therapeutic drug monitoring in patients with cystic fibrosis and mycobacterial disease","volume":"14","author":"Gilljam","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2024.01.005_bib0064","article-title":"Eradication of nontuberculous mycobacteria in people with cystic fibrosis treated with elexacaftor\/tezacaftor\/ivacaftor: a multicenter cohort study","author":"Wiesel","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0065","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jcf.2017.04.005","article-title":"Standardized treatment of pulmonary exacerbations (STOP) study: observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations","volume":"16","author":"Sanders","year":"2017","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0066","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1164\/rccm.202102-0461OC","article-title":"A randomized clinical trial of antimicrobial duration for cystic fibrosis pulmonary exacerbation treatment","volume":"204","author":"Goss","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.01.005_bib0067","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jcf.2017.04.003","article-title":"Standardized treatment of pulmonary exacerbations (STOP) study: physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary Exacerbations","volume":"16","author":"West","year":"2017","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0068","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jcf.2021.11.009","article-title":"Association of site of treatment with clinical outcomes following intravenous antimicrobial treatment of a pulmonary exacerbation","volume":"21","author":"Sanders","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0069","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1378\/chest.121.1.64","article-title":"Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis","volume":"121","author":"Britto","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2024.01.005_bib0070","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/aje\/153.4.345","article-title":"Predictive 5-year survivorship model of cystic fibrosis","volume":"153","author":"Liou","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jcf.2024.01.005_bib0071","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1164\/rccm.200909-1421OC","article-title":"Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation","volume":"182","author":"Sanders","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.01.005_bib0072","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2024.01.005_bib0073","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jcf.2018.06.003","article-title":"Impact of a program ensuring consistent response to acute drops in lung function in children with cystic fibrosis","volume":"17","author":"Schechter","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0074","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jcf.2018.10.001","article-title":"Prevalence, geographic risk factor, and development of a standardized protocol for fungal isolation in cystic fibrosis: Results from the international prospective study \"MFIP\"","volume":"18","author":"Delhaes","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0075","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1164\/rccm.201810-1919OC","article-title":"Changing prevalence of lower airway infections in young children with cystic fibrosis","volume":"200","author":"Breuer","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.01.005_bib0076","doi-asserted-by":"crossref","DOI":"10.1002\/ppul.24126","article-title":"The myriad challenges of respiratory fungal infection in cystic fibrosis","author":"Tracy","year":"2018","journal-title":"Pediatr Pulmonol"},{"issue":"Suppl 3","key":"10.1016\/j.jcf.2024.01.005_bib0077","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1086\/376525","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis\u2013state of the art: Cystic Fibrosis Foundation Consensus Conference","volume":"37","author":"Stevens","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcf.2024.01.005_bib0078","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jcf.2021.07.008","article-title":"Clinician variability in the diagnosis and treatment of aspergillus fumigatus-related conditions in cystic fibrosis: an international survey","volume":"21","author":"Hong","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0079","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/cea.12141","article-title":"Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria","volume":"43","author":"Agarwal","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jcf.2024.01.005_bib0080","doi-asserted-by":"crossref","first-page":"1909-30 e4","DOI":"10.1016\/j.jaip.2020.12.064","article-title":"Biomarkers for the diagnosis of allergic bronchopulmonary aspergillosis in cystic fibrosis: a systematic review and meta-analysis","volume":"9","author":"Li","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jcf.2024.01.005_bib0081","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.jcf.2019.02.002","article-title":"CT evaluation of hyperattenuating mucus to diagnose allergic bronchopulmonary aspergillosis in the special condition of cystic fibrosis","volume":"18","author":"Refait","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0082","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2147\/IDR.S63621","article-title":"Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy","volume":"9","author":"Burgel","year":"2016","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jcf.2024.01.005_bib0083","article-title":"Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis","volume":"9","author":"Jat","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2024.01.005_bib0084","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jcf.2019.07.011","article-title":"Omalizumab for asthma and allergic bronchopulmonary aspergillosis in adults with cystic fibrosis","volume":"19","author":"Koutsokera","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0085","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1378\/chest.09-1103","article-title":"The effect of chronic infection with aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis","volume":"137","author":"Amin","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2024.01.005_bib0086","doi-asserted-by":"crossref","DOI":"10.1513\/AnnalsATS.202210-852OC","article-title":"The Clinical Association between Aspergillus fumigatus and Respiratory Outcomes in Adolescents and Adults with Cystic Fibrosis","author":"O'Dea","year":"2023","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2024.01.005_bib0087","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75886-w","article-title":"Risk factors for respiratory aspergillus fumigatus in german cystic fibrosis patients and impact on lung function","volume":"10","author":"D\u00fcesberg","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcf.2024.01.005_bib0088","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11046-017-0190-0","article-title":"Aspergillus bronchitis in patients with cystic fibrosis","volume":"183","author":"Brandt","year":"2018","journal-title":"Mycopathologia"},{"key":"10.1016\/j.jcf.2024.01.005_bib0089","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1378\/chest.130.1.222","article-title":"Aspergillus bronchitis in cystic fibrosis","volume":"130","author":"Shoseyov","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2024.01.005_bib0090","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jcf.2018.08.012","article-title":"Combined antifungal therapy is superior to monotherapy in pulmonary scedosporiosis in cystic fibrosis","volume":"18","author":"Schwarz","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0091","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/resp.12227","article-title":"Australian standards of care for cystic fibrosis-related diabetes","volume":"19","author":"Middleton","year":"2014","journal-title":"Respirology"},{"key":"10.1016\/j.jcf.2024.01.005_bib0092","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/pedi.13453","article-title":"ISPAD clinical practice consensus guidelines 2022: management of cystic fibrosis-related diabetes in children and adolescents","volume":"23","author":"Ode","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jcf.2024.01.005_bib0093","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/dc10-1604","article-title":"Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis","volume":"34","author":"Brodsky","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2024.01.005_bib0094","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jcf.2019.05.005","article-title":"Peak OGTT glucose is associated with lower lung function in young children with cystic fibrosis","volume":"19","author":"Prentice","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2023.101444","article-title":"Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis","volume":"49","author":"Weiss","year":"2023","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jcf.2024.01.005_bib0096","unstructured":"Cystic Fibrosis Trust. Management of cystic fibrosis diabetes. 2022. https:\/\/www.cysticfibrosis.org.uk\/sites\/default\/files\/2022-12\/CF%20Diabetes%20Consensus%20FINAL_0.pdf Date accessed: 23 October 2023."},{"key":"10.1016\/j.jcf.2024.01.005_bib0097","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jada.2008.02.020","article-title":"Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review","volume":"108","author":"Stallings","year":"2008","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.jcf.2024.01.005_bib0098","first-page":"e41697","article-title":"The effects of elexacaftor, tezacaftor, and ivacaftor (ETI) on blood glucose in patients with cystic fibrosis: a systematic review","volume":"15","author":"Salazar-Barragan","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jcf.2024.01.005_bib0099","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/hep.24183","article-title":"Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis-associated liver disease","volume":"53","author":"Witters","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jcf.2024.01.005_bib0100","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/MPG.0000000000002694","article-title":"Cystic fibrosis-related liver disease is associated with increased disease burden and endocrine comorbidities","volume":"70","author":"Singh","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2024.01.005_bib0101","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jhep.2011.03.028","article-title":"Liver disease in adult patients with cystic fibrosis: a frequent and independent prognostic factor associated with death or lung transplantation","volume":"55","author":"Chryssostalis","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcf.2024.01.005_bib0102","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jcf.2021.10.014","article-title":"Gamma-glutamyl transpeptidase-to-platelet ratio as a biomarker of liver disease and hepatic fibrosis severity in paediatric cystic fibrosis","volume":"21","author":"Calvopina","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0103","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/liv.15572","article-title":"Risk factors for more rapid progression of severe liver fibrosis in children with cystic fibrosis-related liver disease: a multi-center study validated by liver biopsy","volume":"43","author":"Sakhuja","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.jcf.2024.01.005_bib0104","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cgh.2016.03.041","article-title":"Features of severe liver disease with portal hypertension in patients with cystic fibrosis","volume":"14","author":"Stonebraker","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jcf.2024.01.005_bib0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcf.2022.10.002","article-title":"Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosis","volume":"22","author":"Southern","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0106","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.914790","article-title":"The exocrine pancreas in cystic fibrosis in the era of cftr modulation: a mini review","volume":"10","author":"McKay","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jcf.2024.01.005_bib0107","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/j.gastro.2010.09.046","article-title":"Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis","volume":"140","author":"Ooi","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcf.2024.01.005_bib0108","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1210\/jc.2004-1629","article-title":"Guide to bone health and disease in cystic fibrosis","volume":"90","author":"Aris","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcf.2024.01.005_bib0109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-009-9316-9","article-title":"The prevalence of osteoporosis, osteopenia, and fractures among adults with cystic fibrosis: a systematic literature review with meta-analysis","volume":"86","author":"Paccou","year":"2010","journal-title":"Calcif Tissue Int"},{"issue":"Suppl 2","key":"10.1016\/j.jcf.2024.01.005_bib0110","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S1569-1993(11)60004-0","article-title":"European cystic fibrosis bone mineralisation guidelines","volume":"10","author":"Sermet-Gaudelus","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0111","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jcf.2024.01.005_bib0112","article-title":"Bisphosphonates for osteoporosis in people with cystic fibrosis","volume":"1","author":"Jeffery","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2024.01.005_bib0113","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1089\/end.2021.0151","article-title":"Systematic review of the prevalence of kidney stones in cystic fibrosis","volume":"35","author":"Moryousef","year":"2021","journal-title":"J Endourol"},{"key":"10.1016\/j.jcf.2024.01.005_bib0114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(03)00403-7","article-title":"The association of nephrolithiasis with cystic fibrosis","volume":"42","author":"Gibney","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jcf.2024.01.005_bib0115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/oxfordjournals.aje.a113297","article-title":"Frequency of urolithiasis in a prepaid medical care program","volume":"115","author":"Hiatt","year":"1982","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jcf.2024.01.005_bib0116","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1067\/mpd.2002.120694","article-title":"Antibiotic treatment-induced tubular dysfunction as a risk factor for renal stone formation in cystic fibrosis","volume":"140","author":"Bohles","year":"2002","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2024.01.005_bib0117","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s00467-015-3097-3","article-title":"Risk factors for acute kidney injury during aminoglycoside therapy in patients with cystic fibrosis","volume":"30","author":"Downes","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jcf.2024.01.005_bib0118","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/thx.2006.067595","article-title":"Survey of acute renal failure in patients with cystic fibrosis in the UK","volume":"62","author":"Bertenshaw","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2024.01.005_bib0119","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/thx.2007.088757","article-title":"Case-control study of acute renal failure in patients with cystic fibrosis in the UK","volume":"63","author":"Smyth","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2024.01.005_bib0120","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1164\/rccm.201105-0932OC","article-title":"Risk factors for chronic kidney disease in adults with cystic fibrosis","volume":"184","author":"Quon","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.01.005_bib0121","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2602653","article-title":"Glomerular and tubular renal function after repeated once-daily tobramycin courses in cystic fibrosis patients","volume":"2017","author":"Stehling","year":"2017","journal-title":"Pulm Med"},{"key":"10.1016\/j.jcf.2024.01.005_bib0122","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jcf.2017.11.001","article-title":"Prevalence and characteristics of chronic kidney disease among Danish adults with cystic fibrosis","volume":"17","author":"Berg","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0123","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1378\/chest.11-1926","article-title":"Risk of post-lung transplant renal dysfunction in adults with cystic fibrosis","volume":"142","author":"Quon","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2024.01.005_bib0124","first-page":"1","article-title":"Clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.jcf.2024.01.005_bib0125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ppul.20138","article-title":"Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use","volume":"39","author":"Al-Aloul","year":"2005","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.01.005_bib0126","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MPG.0b013e3181a6e01d","article-title":"Defining DIOS and constipation in cystic fibrosis with a multicentre study on the incidence, characteristics, and treatment of DIOS","volume":"50","author":"Houwen","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2024.01.005_bib0127","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jcf.2021.08.021","article-title":"Diagnosing constipation in patients with cystic fibrosis applying ESPGHAN criteria","volume":"21","author":"Stefano","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0128","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jcf.2022.04.003","article-title":"Constipation and cystic fibrosis. Slow movement","volume":"21","author":"van der Doef","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0129","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jcf.2021.11.014","article-title":"Intestinal function and transit associate with gut microbiota dysbiosis in cystic fibrosis","volume":"21","author":"Marsh","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"Suppl 2","key":"10.1016\/j.jcf.2024.01.005_bib0130","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S1569-1993(11)60005-2","article-title":"Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients","volume":"10","author":"Colombo","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0131","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/jpc.13096","article-title":"High ambient temperature and risk of intestinal obstruction in cystic fibrosis","volume":"52","author":"Ooi","year":"2016","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.jcf.2024.01.005_bib0132","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jcf.2016.02.002","article-title":"International prospective study of distal intestinal obstruction syndrome in cystic fibrosis: associated factors and outcome","volume":"15","author":"Munck","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0133","article-title":"Interventions for treating distal intestinal obstruction syndrome (DIOS) in cystic fibrosis","volume":"12","author":"Gilchrist","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2024.01.005_bib0134","article-title":"Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis","volume":"12","author":"Carroll","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2024.01.005_bib0135","first-page":"68","article-title":"Question 8: How should distal intestinal obstruction syndrome [DIOS] be managed?","volume":"21","author":"Groves","year":"2017","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jcf.2024.01.005_bib0136","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1053\/j.gastro.2017.12.012","article-title":"Cystic fibrosis colorectal cancer screening consensus recommendations","volume":"154","author":"Hadjiliadis","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcf.2024.01.005_bib0137","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jcf.2022.10.001","article-title":"The risk of colorectal cancer in individuals with mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene: An English population-based study","volume":"22","author":"Birch","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0138","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.chest.2021.09.003","article-title":"Cancer in cystic fibrosis: a narrative review of prevalence, risk factors, screening, and treatment challenges: adult cystic fibrosis series","volume":"161","author":"Maisonneuve","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2024.01.005_bib0139","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1002\/ijc.24679","article-title":"Cancer risk among patients with cystic fibrosis and their first-degree relatives","volume":"125","author":"Johannesson","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcf.2024.01.005_bib0140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13256-021-03234-1","article-title":"Malignancies in patients with cystic fibrosis: a case series","volume":"16","author":"Appelt","year":"2022","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.jcf.2024.01.005_bib0141","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2017.12.011","article-title":"Cost-effectiveness of screening individuals with cystic fibrosis for colorectal cancer","author":"Gini","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcf.2024.01.005_bib0142","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/thoraxjnl-2014-205983","article-title":"Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of The International Depression Epidemiological Study across nine countries","volume":"69","author":"Quittner","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2024.01.005_bib0143","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106955","article-title":"Mental health screening in cystic fibrosis as an intervention: patient and caregiver feedback on improving these processes","volume":"202","author":"Landau","year":"2022","journal-title":"Respir Med"},{"key":"10.1016\/j.jcf.2024.01.005_bib0144","first-page":"103","article-title":"Breaking the diagnosis of cystic fibrosis to parents: a process not a one-off event","volume":"35","author":"Bryon","year":"2020","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jcf.2024.01.005_bib0145","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s10567-021-00345-5","article-title":"Anxiety in children with cystic fibrosis and their parents: a systematic review","volume":"24","author":"Kimball","year":"2021","journal-title":"Clin Child Fam Psychol Rev"},{"key":"10.1016\/j.jcf.2024.01.005_bib0146","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00127-022-02307-w","article-title":"Depression and anxiety prevalence in people with cystic fibrosis and their caregivers: a systematic review and meta-analysis","volume":"58","author":"Lord","year":"2023","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"10.1016\/j.jcf.2024.01.005_bib0147","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4187\/respcare.06356","article-title":"Health-related quality of life in adolescents and adults with cystic fibrosis: physical and mental health predictors","volume":"64","author":"Cronly","year":"2019","journal-title":"Respir Care"},{"key":"10.1016\/j.jcf.2024.01.005_bib0148","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1513\/AnnalsATS.201408-393OC","article-title":"A systematic review of factors associated with health-related quality of life in adolescents and adults with cystic fibrosis","volume":"12","author":"Habib","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2024.01.005_bib0149","article-title":"Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis","volume":"2","author":"Smith","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2024.01.005_bib0150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcf.2008.09.007","article-title":"High treatment burden in adults with cystic fibrosis: challenges to disease self-management","volume":"8","author":"Sawicki","year":"2009","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0151","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/MCP.0000000000000727","article-title":"Changing landscape: psychological care in the era of cystic fibrosis transmembrane conductance regulator modulators","volume":"26","author":"Havermans","year":"2020","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jcf.2024.01.005_bib0152","first-page":"23","article-title":"Transition to adult care in cystic fibrosis: The challenges and the structure","volume":"41","author":"Singh","year":"2022","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jcf.2024.01.005_bib0153","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jpeds.2019.03.035","article-title":"Impact of cystic fibrosis on unaffected siblings: a systematic review","volume":"210","author":"Chudleigh","year":"2019","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2024.01.005_bib0154","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The future of cystic fibrosis care: a global perspective","volume":"8","author":"Bell","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcf.2024.01.005_bib0155","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/thoraxjnl-2015-207488","article-title":"International committee on mental health in cystic fibrosis: cystic fibrosis foundation and european cystic fibrosis society consensus statements for screening and treating depression and anxiety","volume":"71","author":"Quittner","year":"2016","journal-title":"Thorax"},{"issue":"Suppl 1","key":"10.1016\/j.jcf.2024.01.005_bib0156","first-page":"S107","article-title":"Promoting emotional wellness in children with CF, part II: mental health assessment and intervention","volume":"56","author":"Georgiopoulos","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.01.005_bib0157","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/ppul.24414","article-title":"Assessing psychosocial risk in pediatric cystic fibrosis","volume":"54","author":"Filigno","year":"2019","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.01.005_bib0158","unstructured":"Georgiopoulos A., Smith B., Quittner A. Integrating patient-reported outcomes into research a clinical practice: measures of health-related quality of life and mental health. In: Wilmott RW, Boat TF, Bush A, Chernick V, Deterding RR, Ratjen F, editors. Kendig textbook of disorders of the respiratory tract in children. 10th ed. Philadelphia, PA: Elsevier Health Sciences; in press."},{"key":"10.1016\/j.jcf.2024.01.005_bib0159","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jcf.2019.01.013","article-title":"Social support is associated with fewer reported symptoms and decreased treatment burden in adults with cystic fibrosis","volume":"18","author":"Flewelling","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0160","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.pec.2020.02.025","article-title":"Misunderstandings, misperceptions, and missed opportunities: perspectives on adherence barriers from people with CF, caregivers, and CF team members","volume":"103","author":"Eaton","year":"2020","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.jcf.2024.01.005_bib0161","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jcf.2012.12.009","article-title":"Treatment complexity in cystic fibrosis: trends over time and associations with site-specific outcomes","volume":"12","author":"Sawicki","year":"2013","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0162","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jcf.2019.11.010","article-title":"Prevalence of unmet palliative care needs in adults with cystic fibrosis","volume":"19","author":"Trandel","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0163","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jcf.2022.04.011","article-title":"Ways of coping and survival in cystic fibrosis: a 20-year longitudinal study","volume":"22","author":"Abbott","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0164","article-title":"Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis","volume":"3","author":"Dawson","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2024.01.005_bib0165","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jcf.2015.08.005","article-title":"CF healthcare workers feel unprepared in providing suitable end of life care and desire more education: results of a nationwide survey","volume":"15","author":"Goggin","year":"2016","journal-title":"J Cyst Fibros"},{"issue":"Suppl 1","key":"10.1016\/j.jcf.2024.01.005_bib0166","first-page":"S69","article-title":"Enhancing care for individuals with advanced cystic fibrosis lung disease","volume":"56","author":"Kapnadak","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.01.005_bib0167","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.jand.2020.03.015","article-title":"Academy of nutrition and dietetics: 2020 cystic fibrosis evidence analysis center evidence-based nutrition practice guideline","volume":"121","author":"McDonald","year":"2021","journal-title":"J Acad Nutr Diet"},{"key":"10.1016\/j.jcf.2024.01.005_bib0168","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.clnu.2016.03.004","article-title":"ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis","volume":"35","author":"Turck","year":"2016","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jcf.2024.01.005_bib0169","doi-asserted-by":"crossref","first-page":"d1008","DOI":"10.1136\/bmj.d1008","article-title":"Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007","volume":"342","author":"George","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jcf.2024.01.005_bib0170","first-page":"4","article-title":"Nutritional management of cystic fibrosis - an update for the 21st century","volume":"26","author":"Collins","year":"2018","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jcf.2024.01.005_bib0171","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000406.pub4","article-title":"Oral calorie supplements for cystic fibrosis","author":"Smyth","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2024.01.005_bib0172","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2022.111725","article-title":"Improving nutrition in cystic fibrosis: a systematic literature review","volume":"102","author":"Mielus","year":"2022","journal-title":"Nutrition"},{"key":"10.1016\/j.jcf.2024.01.005_bib0173","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jcf.2016.08.004","article-title":"Enteral tube feeding for individuals with cystic fibrosis: cystic fibrosis foundation evidence-informed guidelines","volume":"15","author":"Schwarzenberg","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0174","article-title":"Enteral tube feeding for cystic fibrosis","volume":"7","author":"Shimmin","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2024.01.005_bib0175","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/MCP.0000000000000430","article-title":"The optimal approach to nutrition and cystic fibrosis: latest evidence and recommendations","volume":"23","author":"Hollander","year":"2017","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jcf.2024.01.005_bib0176","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jcf.2020.02.015","article-title":"Cystic fibrosis foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease","volume":"19","author":"Kapnadak","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0177","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1164\/rccm.201002-0157OC","article-title":"Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax","volume":"182","author":"Flume","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.01.005_bib0178","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.chest.2021.06.017","article-title":"Pulmonary complications in cystic fibrosis: past, present, and future: adult cystic fibrosis series","volume":"160","author":"Mingora","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2024.01.005_bib0179","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0022-3476(89)80553-0","article-title":"Nocturnal home oxygen in the treatment of hypoxemic cystic fibrosis patients","volume":"114","author":"Zinman","year":"1989","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2024.01.005_bib0180","article-title":"Oxygen therapy for cystic fibrosis","volume":"2013","author":"Elphick","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2024.01.005_bib0181","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jcf.2018.11.006","article-title":"Non-invasive ventilation and clinical outcomes in cystic fibrosis: Findings from the UK CF registry","volume":"18","author":"Archangelidi","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0182","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/resp.13604","article-title":"Non-invasive ventilation versus oxygen therapy in cystic fibrosis: a 12-month randomized trial","volume":"24","author":"Milross","year":"2019","journal-title":"Respirology"},{"key":"10.1016\/j.jcf.2024.01.005_bib0183","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1016\/j.jcf.2021.05.011","article-title":"Non-invasive ventilation is associated with long-term improvements in lung function and gas exchange in cystic fibrosis adults with hypercapnic respiratory failure","volume":"20","author":"Wadsworth","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0184","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jcf.2011.11.006","article-title":"Long-term non-invasive ventilation in cystic fibrosis \u2013 experience over two decades","volume":"11","author":"Flight","year":"2012","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0185","article-title":"Nocturnal non invasive ventilation in normocapnic cystic fibrosis patients: a pilot study","volume":"92","author":"Papale","year":"2021","journal-title":"Acta Biomed"},{"key":"10.1016\/j.jcf.2024.01.005_bib0186","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/thx.2007.082602","article-title":"Randomised placebo controlled trial of non-invasive ventilation for hypercapnia in cystic fibrosis","volume":"63","author":"Young","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2024.01.005_bib0187","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4187\/respcare.07862","article-title":"Noninvasive ventilation in cystic fibrosis: clinical indications and outcomes in a large UK adult cystic fibrosis center","volume":"66","author":"Spoletini","year":"2021","journal-title":"Respir Care"},{"key":"10.1016\/j.jcf.2024.01.005_bib0188","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcf.2019.03.002","article-title":"Lung transplant referral for individuals with cystic fibrosis: cystic fibrosis foundation consensus guidelines","volume":"18","author":"Ramos","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0189","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1378\/chest.102.3.846","article-title":"Nocturnal nasal IPPV stabilizes patients with cystic fibrosis and hypercapnic respiratory failure","volume":"102","author":"Piper","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2024.01.005_bib0190","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13613-018-0432-4","article-title":"High-flow nasal oxygen versus noninvasive ventilation in adult patients with cystic fibrosis: a randomized crossover physiological study","volume":"8","author":"Sklar","year":"2018","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.jcf.2024.01.005_bib0191","doi-asserted-by":"crossref","DOI":"10.4187\/respcare.09890","article-title":"Nocturnal high-flow nasal cannula therapy and sinonasal symptoms during cystic fibrosis exacerbations","author":"Davis","year":"2023","journal-title":"Respir Care"},{"key":"10.1016\/j.jcf.2024.01.005_bib0192","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.chest.2018.07.025","article-title":"Critical care of the adult patient with cystic fibrosis","volume":"155","author":"King","year":"2019","journal-title":"Chest."},{"key":"10.1016\/j.jcf.2024.01.005_bib0193","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.healun.2021.07.005","article-title":"Consensus document for the selection of lung transplant candidates: an update from the international society for heart and lung transplantation","volume":"40","author":"Leard","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jcf.2024.01.005_bib0194","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/621342","article-title":"Practical guidelines: lung transplantation in patients with cystic fibrosis","volume":"2014","author":"Hirche","year":"2014","journal-title":"Pulm Med"},{"key":"10.1016\/j.jcf.2024.01.005_bib0195","article-title":"Impact of a high emergency lung transplantation programme for cystic fibrosis in France: insight from a comparison with Canada","volume":"59","author":"Coriati","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2024.01.005_bib0196","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1164\/rccm.201902-0252OC","article-title":"Effect of including important clinical variables on accuracy of the lung allocation score for cystic fibrosis and chronic obstructive pulmonary disease","volume":"200","author":"Lehr","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.01.005_bib0197","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1164\/rccm.202011-4153OC","article-title":"Rapid improvement after starting elexacaftor-tezacaftor-ivacaftor in patients with cystic fibrosis and advanced pulmonary disease","volume":"204","author":"Burgel","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.01.005_bib0198","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jcf.2022.01.012","article-title":"Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis","volume":"21","author":"Martin","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0199","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1164\/rccm.202109-2121LE","article-title":"Major decrease in lung transplantation for patients with cystic fibrosis in France","volume":"205","author":"Martin","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.01.005_bib0200","article-title":"Lung transplantation for end-stage cystic fibrosis before and after the availability of elexacaftor\u2013tezacaftor\u2013ivacaftor, Germany, 2012\u20132021","volume":"61","author":"Ringshausen","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2024.01.005_bib0201","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jcf.2023.03.002","article-title":"Real-world safety and effectiveness of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis: Interim results of a long-term registry-based study","volume":"22","author":"Bower","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0202","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jcf.2021.12.002","article-title":"Outcomes following lung re-transplantation in patients with cystic fibrosis","volume":"21","author":"Chan","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0203","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.healun.2021.04.011","article-title":"Cystic fibrosis foundation consensus statements for the care of cystic fibrosis lung transplant recipients","volume":"40","author":"Shah","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jcf.2024.01.005_bib0204","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jcf.2023.02.011","article-title":"Position paper: models of post-transplant care for individuals with cystic fibrosis","volume":"22","author":"McKone","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0205","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jcf.2020.07.017","article-title":"Projecting the impact of delayed access to elexacaftor\/tezacaftor\/ivacaftor for people with cystic fibrosis","volume":"20","author":"Stanojevic","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0206","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chest.2022.07.004","article-title":"The changing epidemiology of cystic fibrosis: the implications for adult care","volume":"163","author":"Burgel","year":"2023","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2024.01.005_bib0207","doi-asserted-by":"crossref","DOI":"10.1136\/bmjoq-2019-000861","article-title":"Improving end-of-life care for adults with cystic fibrosis: an improvement project","volume":"9","author":"Cathcart","year":"2020","journal-title":"BMJ Open Qual"},{"key":"10.1016\/j.jcf.2024.01.005_bib0208","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jcf.2019.08.009","article-title":"Addressing the burden of illness in adults with cystic fibrosis with screening and triage: an early intervention model of palliative care","volume":"19","author":"Dhingra","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.005_bib0209","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.1136\/bmjspcare-2019-001819","article-title":"Associations between demographic characteristics and unmet supportive care needs in adults with cystic fibrosis","volume":"12","author":"Obregon","year":"2022","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.jcf.2024.01.005_bib0210","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/ppul.24655","article-title":"Clinical communication preferences in cystic fibrosis and strategies to optimize care","volume":"55","author":"Cooley","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.01.005_bib0211","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1089\/jpm.2020.0725","article-title":"Assessing practices, beliefs, and attitudes about palliative care among people with cystic fibrosis, their caregivers, and clinicians: results of a content analysis","volume":"24","author":"Basile","year":"2021","journal-title":"J Palliat Med"},{"key":"10.1016\/j.jcf.2024.01.005_bib0212","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jpainsymman.2019.08.017","article-title":"Opportunities to improve utilization of palliative care among adults with cystic fibrosis: a systematic review","volume":"58","author":"Marmor","year":"2019","journal-title":"J Pain Symptom Manag"},{"key":"10.1016\/j.jcf.2024.01.005_bib0213","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pec.2008.09.007","article-title":"Impact of communication training on physician expression of empathy in patient encounters","volume":"75","author":"Bonvicini","year":"2009","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.jcf.2024.01.005_bib0214","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jcf.2015.03.005","article-title":"Development and evaluation of a palliative care curriculum for cystic fibrosis healthcare providers","volume":"15","author":"Linnemann","year":"2016","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324000055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324000055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T08:22:39Z","timestamp":1772353359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199324000055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":214,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1569199324000055"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2024.01.005","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2024.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}